Gut microbial metabolite trimethylamine N-oxide as a novel predictor for adverse cardiovascular events after PCI: a systematic review and dose-response meta-analysis

Gut microbial metabolite trimethylamine N-oxide as a novel predictor for adverse cardiovascular events after PCI: a systematic review and dose-response meta-analysis

Abstract Background Cardiovascular diseases are the leading cause of mortality worldwide, with acute coronary syndrome (ACS) being particularly fatal. Percutaneous coronary intervention (PCI) is a key treatment for ACS; however, major adverse cardiovascular events (MACE) frequently occur postoperati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chunyu Zhang, Jinyu He, Yujia Huo, Lin Liu, Yong Xie, Yufei Meng, Gang Wei, Li Deng, Yang Jiang, Jian Feng
Format:	Article
Language:	English
Published:	BMC 2025-06-01
Series:	Nutrition Journal
Subjects:	Trimethylamine N-oxide Percutaneous coronary intervention Major adverse cardiovascular events All-cause mortality Meta-analysis Dose-response analysis
Online Access:	https://doi.org/10.1186/s12937-025-01159-9
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between trimethylamine N-oxide and prognosis of patients with myocardial infarction: a meta-analysis
by: Xiuqing Li, et al.
Published: (2024-12-01)

Triglyceride to high density lipoprotein cholesterol ratio and major adverse cardiovascular events in ACS patients undergoing PCI
by: Shangxun Zhou, et al.
Published: (2024-12-01)

Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential
by: I. N. Grigorieva
Published: (2022-09-01)

Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis
by: Matthew J. Budoff, et al.
Published: (2025-07-01)

Prospects for the sulfur-containing amino acids medicines usage for trimethylamine-N-oxide biosynthesis modulation in humans
by: I. O. Melnychuk, et al.
Published: (2023-01-01)

Impacts of intestinal microbiota metabolite trimethylamine N-oxide on cardiovascular disease: a bibliometric analysis
by: Xiaohui Leng, et al.
Published: (2025-01-01)

Microbiota γ‐Butyrobetaine Is Associated With Increased Risk of Major Adverse Limb Events in People With Lower Extremity Arterial Disease Undergoing Endovascular Therapy
by: Zheng‐Wei Chen, et al.
Published: (2025-08-01)

Gut Microbe-Generated Metabolite Trimethylamine-N-Oxide and Ischemic Stroke
by: Zhen Li, et al.
Published: (2024-11-01)

Conclusion on the peer review of the pesticide risk assessment of the active substance trimethylamine hydrochloride
by: European Food Safety Authority
Published: (2012-01-01)

Exploring the trimethylamine-degrading genes in the human gut microbiome
by: Yi-Ran Chen, et al.
Published: (2025-06-01)

Trimethylamine N-oxide generation process was influenced by the proportion and source of macronutrients in the diet
by: Chengcheng Wang, et al.
Published: (2024-03-01)

Effects of choline metabolite—trimethylamine N-oxide on immunometabolism in inflammatory bowel disease
by: Siyu Wang, et al.
Published: (2025-07-01)

An Adiabatic-Expansion-Induced Perturbation Study on Gas–Aerosol Partitioning in Ambient Air–Dimethylamine and Trimethylamine (1)
by: Yating Gao, et al.
Published: (2025-05-01)

Research advances of trimethylamine N-oxide and chronic kidney diseases
by: Liu Mei-jun, et al.
Published: (2021-01-01)

Long-term trajectories of apolipoprotein A1 and major adverse cardiovascular events and mortality in a community cohort
by: Yang Chen, et al.
Published: (2025-04-01)

Characteristics and Outcomes of Older Patients Undergoing Protected Percutaneous Coronary Intervention With Impella
by: Philipp Jakob, et al.
Published: (2025-05-01)

Prediction value of serum TMAO on myocardial injury after PCI in patients with coronary heart disease based on decision curve analysis
by: CHEN Guixiu，GUO Cheng，HE Lin
Published: (2025-08-01)

Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health
by: Eugenio Caradonna, et al.
Published: (2025-03-01)

Gut Microbiota-Derived Trimethylamine Promotes Inflammation with a Potential Impact on Epigenetic and Mitochondrial Homeostasis in Caco-2 Cells
by: Laura Bordoni, et al.
Published: (2024-08-01)

Triglyceride glucose index predicts long-term mortality and major adverse cardiovascular events in patients with type 2 diabetes
by: Matilde Sbriscia, et al.
Published: (2025-03-01)

Trimethylamine-N-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body
by: Ylenia Heinrich-Sanchez, et al.
Published: (2025-12-01)

Estimated potassium intake and major adverse cardiovascular events in individuals with type 2 diabetes: a prospective cohort study with trans-ethnic validation
by: Jian-Jun Liu, et al.
Published: (2024-12-01)

Trimethylamine oxide and its possible role in the development and progression of cardiovascular disease
by: A. I. Kochetkov, et al.
Published: (2021-10-01)

Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01)

Association between plasma trimethylamine N-oxide level and atrial fibrillation
by: YANG Wentao, ZHAO Qing, LI Xiangdong, WANG Yutang, LIU Wei
Published: (2025-04-01)

Establishment and validation of post-PCI nomogram in elderly patients with acute coronary syndromes
by: Xing-Yu Zhu, et al.
Published: (2025-03-01)

Trimethylamine N-oxide Supplementation Enhances the Quality of Oocytes in Mice of Polycystic Ovary Syndrome
by: Jiayu Huang, et al.
Published: (2025-05-01)

To MRAs treatment or not? evidence from a meta-analysis of randomized controlled trials of different MRAs on cardiovascular health in heart failure
by: Jinyu He, et al.
Published: (2025-07-01)

A Systematic Review of risk factors for major adverse cardiovascular events in patients with coronary heart disease who underwent percutaneous coronary intervention
by: You Zhai, et al.
Published: (2025-04-01)

Interrelationships of the Intestinal Microbiome, Trimethylamine N-Oxide and Lipopolysaccharide-Binding Protein with Crohn’s Disease Activity
by: Yelena Laryushina, et al.
Published: (2024-12-01)

Prognosis modelling of adverse events for post-PCI treated AMI patients based on inflammation and nutrition indexes
by: Liu Yang, et al.
Published: (2025-01-01)

Platelet-To-Lymphocyte Ratio Efficiency in Predicting Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis
by: He Wang, et al.
Published: (2025-05-01)

Acute kidney injury predicts the risk of adverse cardio renal events and all cause death in southeast Asian people with type 2 diabetes
by: Janus Lee, et al.
Published: (2024-11-01)

The role of trimethylamine N-oxide in disease pathogenesis and the therapeutic potential of traditional Chinese medicine
by: Zizhen Qin, et al.
Published: (2025-07-01)

Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
by: Shan Huang, et al.
Published: (2025-01-01)

Prognostic Role of Basophils to Predict Major Adverse Cardiac Cerebrovascular Events in ST Elevation Myocardial Infarction Patients: Egyptian PCI-Capable Center Experience
by: Walid Mohamed Kamel Ahmed, et al.
Published: (2021-12-01)

Lycopene attenuates trimethylamine-N-oxide-induced senescence in endothelial progenitor cells via the AMPK/SIRT1 pathway
by: Yanfeng Liu, et al.
Published: (2025-12-01)

Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease
by: Yoshihiro Iwasaki, MD, PhD, et al.
Published: (2025-09-01)

Increased indexed proximal aortic diameter is a predictor of poor prognosis in maintenance hemodialysis patients
by: Junwei Xu, et al.
Published: (2024-12-01)

Optical Coherence Tomography-Guided vs. Angiography-Guided Percutaneous Coronary Intervention for Complex Coronary Lesions: A Systematic Review and Meta-Analysis
by: Muhammad Hamza Shuja, et al.
Published: (2025-07-01)